Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia.
Cardiovasc Diabetol. 2021 Jul 9;20(1):139. doi: 10.1186/s12933-021-01323-5.
Cardiovasc Diabetol. 2021.
PMID: 34243779
Free PMC article.